NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness
Clinical trial NCT01591551 · COMPLETED
Trial details
- NCT number
- NCT01591551
- Sponsor
- Cornerstone Health Care, PA
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-08-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.